Differential efficacy of nicotine replacement among overweight and obese women smokers.
Introduction Rates of obesity are higher among more dependent smokers and 37-65% of smokers seeking cessation treatment are overweight or obese. Overweight or obese smokers may possess metabolic and neurobiological features that contribute to difficulty achieving cessation using front-line nicotine...
Автори: | Strong, DR, David, S, Johnstone, E, Aveyard, P, Murphy, M, Munafò, M |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
2014
|
Схожі ресурси
Схожі ресурси
-
Effect on adherence to nicotine replacement therapy of informing smokers their dose is determined by their genotype: a randomised controlled trial.
за авторством: Marteau, T, та інші
Опубліковано: (2012) -
Lack of association of DRD2 rs1800497 (Taq1A) polymorphism with smoking cessation in a nicotine replacement therapy randomized trial
за авторством: Munafo, M, та інші
Опубліковано: (2009) -
Lack of association of DRD2 rs1800497 (Taq1A) polymorphism with smoking cessation in a nicotine replacement therapy randomized trial.
за авторством: Munafò, MR, та інші
Опубліковано: (2009) -
Effect on adherence to nicotine replacement therapy of informing smokers their dose is determined by their genotype: a randomised controlled trial.
за авторством: Theresa M Marteau, та інші
Опубліковано: (2012-01-01) -
Genome-wide association for smoking cessation success: participants in the Patch in Practice trial of nicotine replacement.
за авторством: Uhl, G, та інші
Опубліковано: (2010)